Fair Balance of Prescription Drug Information on Legitimate and Illegitimate Online Pharmacy Websites

Author:

Huhmann Bruce A.1ORCID,Limbu Yam B.2ORCID

Affiliation:

1. Department of Marketing, Virginia Commonwealth University, Richmond, VA 23284, USA

2. Department of Marketing, Montclair State University, Montclair, NJ 07043, USA

Abstract

Patients require important information when prescribed medications. For example, the U.S. Food and Drug Administration (FDA) requires that promotional information includes a fair balance of risks and benefits. This study evaluates how well legitimate online pharmacies (LOPs) and illegitimate online pharmacies (IOPs) comply with the spirit of the FDA’s fair balance guidelines by examining the extent and equivalence of risk and benefit information on their websites. This study analyzed the content of 307 online pharmacy websites. Most (90.3%) communicated drug benefits, while 84.7% provided risks. Both risk and benefit information was moderately extensive. Presentation of risks and benefits differed between online pharmacy types. Compared to LOPs, IOPs were more likely to present risk information but also exaggerate benefits. Four in ten online pharmacies presented a fair balance of risks and benefits. However, LOPs (47.4%) were more likely to present a fair balance than IOPs (36.5%). Interestingly, IOPs were more likely to disclose instructions for use and overdose information than LOPs. These findings underscore the need for regulatory guidelines to encourage online pharmacies to present a fair balance of benefit and risk information. Also, pharmacists should develop online approaches to better fulfill their professional responsibility as drug information providers while maintaining their integrity and objectivity.

Publisher

MDPI AG

Reference32 articles.

1. Content and compliance of pharmaceutical social media marketing;Huhmann;Mark. Intell. Plan.,2016

2. Closing the digital gap: FDA’s oversight of social media;Senak;Pharm. Exec.,2023

3. A review of DTCA techniques: Appraising their success and potential impact on medication users;Babar;Res. Soc. Adm. Pharm.,2018

4. Consumer internet purchasing of medicines using a population sample: A mixed methodology approach;Bowman;Res. Soc. Adm. Pharm.,2020

5. Quality of online pharmacies and websites selling prescription drugs: A systematic review;Orizio;J. Med. Internet Res.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3